BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2021
View Archived Issues
Synthesis and optimization of LRRK2 inhibitors using a CHK1-derived crystallographic surrogate
Read More
New MAP4K4 inhibitors identified for suppressing cardiac muscle cell death
Read More
New sporadic Alzheimer's disease animal model may improve drug testing
Read More
GABA-A alpha5 PAM RO-7015738 presented for neurological disorders
Read More
Genfleet Therapeutics discovers RIP-1 inhibitors
Read More
New IRAK-4/FLT-3 inhibitors identified at PharmaBlock Sciences
Read More
Amgen describes new PRMT5 inhibitors
Read More
New EGFR mutant inhibitors identified at Betta Pharmaceuticals
Read More
New DNA vaccine shows promise against Ebola virus infection
Read More
Microglial activation and tau spreading correlate with Braak stages in AD
Read More
NIH develops PET radioligands targeting CSF-1R for neuroinflammation
Read More
ProQR and Lilly to use Axiomer RNA editing platform to target liver and nervous system disorders
Read More
Update from large animal pilot dosing study of BB-301 for oculopharyngeal muscular dystrophy
Read More
mRNA-1273 vaccine induces antibodies against SARS-CoV-2 variants
Read More
Herantis advances project to combine Nanoform's technology with rhCDNF for Parkinson's disease
Read More
Reprogramming the tumor-immunosuppressive microenvironment to control metastasis
Read More
Researchers give rationale on the development of RAF-selective MEK inhibitors for cancer
Read More
Gut bacteria accumulate multiple therapeutic drugs
Read More
PAQ and Insilico Medicine collaborate to develop therapies through autophagy-dependent degradation
Read More
